Insiders Supernus Pharmaceuticals, Inc.

Equities

Market Closed - Nasdaq Other stock markets 21:00:00 08/05/2024 BST			5-day change	1st Jan Change
31.3 ^USD	+0.48%		+4.06%	+8.15%

05-08	Earnings Flash (SUPN) SUPERNUS PHARMACEUTICALS Reports Q1 Revenue $143.6M, vs. Street Est of $145.8M	MT
05-08	Supernus Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Supernus Pharmaceuticals, Inc. Announces Retirement of John M. Siebert from the Board of Directors	04-24	CI
Supernus Pharmaceuticals Insider Sold Shares Worth $511,677, According to a Recent SEC Filing	03-25	MT
Supernus Pharmaceuticals Insider Sold Shares Worth $436,573, According to a Recent SEC Filing	03-21	MT
Supernus Pharmaceuticals, Inc. Announces Executive Changes	02-21	CI
Supernus Pharmaceuticals Insider Sold Shares Worth $259,151, According to a Recent SEC Filing	11-17	MT
Insider Sell: Supernus Pharmaceuticals	01/09/23	MT
Insider Sell: Supernus Pharmaceuticals	29/08/23	MT
Supernus Pharmaceuticals, Inc. Appoints Bethany L. Sensenig to Board of Directors	21/08/23	CI
Insider Sell: Supernus Pharmaceuticals	16/03/23	MT
Insider Sell: Supernus Pharmaceuticals	06/02/23	MT
Insider Sell: Supernus Pharmaceuticals	20/01/23	MT
Insider Sell: Supernus Pharmaceuticals	19/01/23	MT
Insider Sell: Supernus Pharmaceuticals	19/01/23	MT
Insider Sell: Supernus Pharmaceuticals	22/12/22	MT
Insider Sell: Supernus Pharmaceuticals	02/12/22	MT
Insider Sell: Supernus Pharmaceuticals	15/11/22	MT
Insider Sell: Supernus Pharmaceuticals	23/08/22	MT
Insider Sell: Supernus Pharmaceuticals	18/08/22	MT
Insider Sell: Supernus Pharmaceuticals	17/08/22	MT
Insider Sell: Supernus Pharmaceuticals	11/08/22	MT

No results for this search